Jul 26 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2021 Jun 30, 2020 Mar 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.17 989 mln 4.60
(+18.3 pct) (-9.4 pct) (+8.0 pct)
Operating 279 mln 161 mln 600 mln
(+73.1 pct) (+84.3 pct) (-5.1 pct)
Recurring 281 mln 166 mln 600 mln
(+69.4 pct) (+86.2 pct) (-8.2 pct)
Net 193 mln 124 mln 400 mln
(+55.3 pct) (+183.0 pct) (-4.2 pct)
EPS 47.20 yen 29.75 yen 97.71 yen
Ann Div 15.00 yen 15.00 yen
-Q2 div NIL NIL
-Q4 div 15.00 yen 15.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T